科创板指数达32条，约200万投资者参与配置

Group 1 - The core viewpoint of the article highlights the strong performance of the STAR Market indices in 2025, with the STAR Composite Index achieving a year-to-date increase of 22.51%, outperforming major indices like CSI 300 and SSE 50 [2] - The STAR Market has become a key driver of the recent technology stock rally, particularly in sectors such as AI and innovative pharmaceuticals, with the STAR AI and STAR Chip indices showing cumulative increases of 109.25% and 95.98% respectively since September 24, 2024 [2] - The robust performance of innovative pharmaceutical companies on the STAR Market is notable, with the STAR Innovative Drug Index rising 75.19% year-to-date, significantly outpacing the SSE Biomedicine Index [2] Group 2 - The upward trend in STAR Market indices indicates a deepening "tech valuation" logic in the capital market, supported by reforms and innovations that provide richer valuation anchors for technology assets [3] - The introduction of the STAR Growth Tier, which supports high-quality, unprofitable tech companies to go public, has expanded investment opportunities for investors [3] - The STAR Market now features 32 indices, creating a multi-layered product matrix that attracts approximately 2 million investors, with over 80 STAR Market ETFs listed, totaling more than 250 billion yuan in scale [3] Group 3 - Since the release of the "STAR Market Eight Measures" in 2024, the number of STAR Market ETFs has nearly doubled, with a more than 60% increase in fund product scale [4] - Long-term investors have significantly increased their allocation to STAR Market ETFs, with total allocation exceeding 40 billion yuan by mid-2025, particularly among insurance and corporate pension funds [4] - There is a strong preference among long-term investors for ETFs tracking the STAR 50 Index, with both market value and number of accounts showing positive growth for five consecutive years [4]